| Substance | Relationship Strength | Studies | Trials | Classes | Roles |
|---|
5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid
[no description available] | 2.03 | 1 | 0 | biotins | |
digallic acid
digallic acid: structure given in first source | 1.99 | 1 | 0 | benzoate ester;
gallate ester | |
pyridoxal phosphate
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).. pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal. | 2.08 | 1 | 0 | methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate | coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite |
benzbromarone
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.. benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication. | 2.03 | 1 | 0 | 1-benzofurans;
aromatic ketone | uricosuric drug |
3,4-dihydroxybenzohydroxamic acid
[no description available] | 1.99 | 1 | 0 | benzoic acids | |
erythrosine
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. | 1.95 | 1 | 0 | | |
masoprocol
nordihydroguaretic acid: antioxidant compound found in the creosote bush (Larrea tridentata) | 2.06 | 1 | 0 | catechols;
lignan;
tetrol | antioxidant;
ferroptosis inhibitor;
geroprotector;
plant metabolite |
9,10-phenanthrenequinone
9,10-phenanthrenequinone: structure | 2.03 | 1 | 0 | phenanthrenes | |
2,6-dihydroxyanthraquinone
2,6-dihydroxyanthraquinone: structure given in first source. anthraflavic acid : A dihydroxyanthraquinone that is anthracene substituted by hydroxy groups at C-3 and C-7 and oxo groups at C-9 and C-10. | 2.41 | 1 | 0 | dihydroxyanthraquinone | antimutagen;
plant metabolite |
xanthenes
Xanthenes: Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring. | 1.95 | 1 | 0 | xanthene | |
anthrarufin
1,5-dihydroxyanthraquinone: used in ferric ion sensing as an inclusion complex with beta-cyclodextrin; structure in first source. anthrarufin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 5. | 2.41 | 1 | 0 | dihydroxyanthraquinone | |
benzo(b)fluoranthene
benzo[b]fluoranthene : An ortho- and peri-fused polycyclic arene that consists of a benzene ring fused with a acephenanthrylene ring. | 2.03 | 1 | 0 | ortho- and peri-fused polycyclic arene | mutagen |
chrysophanic acid
chrysophanic acid: RN given refers to parent cpd; structure in Merck, 9th ed, #2260. chrysophanol : A trihydroxyanthraquinone that is chrysazin with a methyl substituent at C-3. It has been isolated from Aloe vera and exhibits antiviral and anti-inflammatory activity. | 2.41 | 1 | 0 | dihydroxyanthraquinone | anti-inflammatory agent;
antiviral agent;
plant metabolite |
anthrarobin
anthrarobin: antipsoriatic; structure. anthrarobin : An anthracenetriol having the three hydroxy substituents at the 1-, 2- and 10-positions. | 2.06 | 1 | 0 | anthracenetriol | allergen |
malononitrile dimer
Malononitrile dimer: has antithyroid activity; inhibits conversion of monoiodotyrosine to diiodotyrosine | 2.03 | 1 | 0 | | |
(4-tert-Butyl-phenoxy)-acetic acid
[no description available] | 2.08 | 1 | 0 | monocarboxylic acid | |
psoromic acid
psoromic acid: structure in first source | 1.99 | 1 | 0 | carbonyl compound | |
1,4,5,8-naphthalenetetracarboxylic acid
1,4,5,8-naphthalenetetracarboxylic acid: structure given in first source | 1.99 | 1 | 0 | | |
amonafide
xanafide: salt formulation of amonafide; DNA-intercalating agent and topoisomerase II inhibitor | 2.06 | 1 | 0 | isoquinolines | |
xanthene-9-carboxylic acid
xanthene-9-carboxylic acid: degradation product of propantheline | 2.41 | 1 | 0 | xanthenes | |
physodic acid
physodic acid: lichen constituent | 1.99 | 1 | 0 | carbonyl compound | |
toxoflavin
toxoflavin: azapteridine antibiotic; structure. toxoflavin : A pyrimidotriazine that is 1,6-dimethyl-1,5,6,7-tetrahydropyrimido[5,4-e][1,2,4]triazine with oxo groups at positions 5 and 7. | 2.03 | 1 | 0 | carbonyl compound;
pyrimidotriazine | antibacterial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
toxin;
virulence factor;
Wnt signalling inhibitor |
5,5'-methylenedisalicylic acid
5,5'-methylenedisalicylic acid: inhibits attachment of ribosomes to microsomal membranes; RN given refers to parent cpd; structure in first source & Merck Index, 9th ed, #5934 | 1.99 | 1 | 0 | | |
atranorin
atranorin: RN given refers to parent cpd; structure given in first source | 1.99 | 1 | 0 | carbonyl compound | |
fluorone black
fluorone Black: structure | 7.38 | 2 | 0 | | |
6-hydroxyflavone
6-hydroxyflavone: antioxidant; structure in first source | 2.06 | 1 | 0 | hydroxyflavonoid | |
cryptopine
cryptopine: structure | 2.06 | 1 | 0 | | |
9-hydroxyphenylfluoron
[no description available] | 2.54 | 2 | 0 | | |
juncusol
juncusol: cytotoxic dihydro phenanthrene from Estuarian marsh plant Juncus roemerianus; structure | 2.06 | 1 | 0 | | |
uvaretin
uvaretin: chloroform extract of Uvaria acuminata Oliv.; structure. uvaretin : A member of the class of dihydrochalcones that is 1,3-diphenylpropan-1-one in which the phenyl group that is bonded to the carbonyl group is substituted by hydroxy groups at positions 2 and 4, an o-hydroxybenzyl group at position 3, and a methoxy group at position 6. A cytotoxic natural product found particularly in Uvaria acuminata and Uvaria chamae. | 2.41 | 1 | 0 | aromatic ether;
dihydrochalcones;
polyketide;
resorcinol | antineoplastic agent;
plant metabolite |
stictic acid
stictic acid: antioxidant from lichen, Usnea articulata; structure in first source | 1.99 | 1 | 0 | aromatic ether | |
diffractaic acid
difractaic acid: from Lichen, Usnea steineri; active against Gram-positive, multidrug-resistant bacteria; structure in first source | 1.99 | 1 | 0 | carbonyl compound | |
2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one
2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one : A pentahydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 6, 7, 8, and 4' respectively. | 2.08 | 1 | 0 | pentahydroxyflavone | |
3,4,5-trihydroxybenzohydroxamic acid
[no description available] | 1.99 | 1 | 0 | | |
effusol
effusol: from the pith of Juncus effusus L.; structure in first source | 2.06 | 1 | 0 | | |
6-hydroxydopa
6-hydroxydopa: RN given refers to cpd without isomeric designation | 2.03 | 1 | 0 | non-proteinogenic alpha-amino acid | |
pannarin
pannarin: photoirradiation of above cpd leads to its decomposition which is reduced by oxygen. pannarin : A member of the class of depsidones that is 11H-dibenzo[b,e][1,4]dioxepine substituted by methyl groups at positions 1,6 and 9, chloro group at position 2, hydroxy group at position 3, formyl group at position 4, methoxy group at position 8 and an oxo group at position 11. It is a lichen metabolite isolated from several Psoroma species. | 1.99 | 1 | 0 | aldehyde;
aromatic ether;
depsidones;
organic heterotricyclic compound;
organochlorine compound;
phenols | antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lichen metabolite |
biotin
vitamin B7 : Any member of a group of vitamers that belong to the chemical structural class called biotins that exhibit biological activity against vitamin B7 deficiency. Vitamin B7 deficiency is very rare in individuals who take a normal balanced diet. Foods rich in biotin are egg yolk, liver, cereals, vegetables (spinach, mushrooms) and rice. Symptoms associated with vitamin B7 deficiency include thinning hair, scaly skin rashes around eyes, nose and mouth, and brittle nails. The vitamers include biotin and its ionized and salt forms. | 2.46 | 2 | 0 | biotins;
vitamin B7 | coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite |
erlotinib
[no description available] | 2.41 | 1 | 0 | aromatic ether;
quinazolines;
secondary amino compound;
terminal acetylenic compound | antineoplastic agent;
epidermal growth factor receptor antagonist;
protein kinase inhibitor |
1-Anilino-9,10-dioxo-2-anthroic acid
[no description available] | 2.08 | 1 | 0 | anthracenes | |
qlt 0267
[no description available] | 2.06 | 1 | 0 | | |
4-[(1,3-dimethyl-2,6-dioxo-7H-purin-8-yl)methylamino]benzoic acid
[no description available] | 2.48 | 2 | 0 | oxopurine | |
3-(3-pyridinyl)propanoic acid
[no description available] | 2.08 | 1 | 0 | pyridines | |
5-(2-naphthalenylmethylidene)-1,3-diazinane-2,4,6-trione
[no description available] | 2.06 | 1 | 0 | naphthalenes | |
3-(prop-2-enylthio)-5-thiophen-2-yl-1H-1,2,4-triazole
[no description available] | 2.06 | 1 | 0 | aryl sulfide | |
desthiobiotin
desthiobiotin: RN given refers to cpd without isomeric designation; structure. (4R,5S)-dethiobiotin : The (4R,5S)-isomer of dethiobiotin. | 2.03 | 1 | 0 | dethiobiotin | |
1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione
[no description available] | 2.03 | 1 | 0 | pyrimidotriazine | |
(+)-usnic acid
[no description available] | 1.99 | 1 | 0 | usnic acid | |
5-bromo-3-ethyl-1H-indole-2-carboxylic acid
[no description available] | 2.03 | 1 | 0 | indolyl carboxylic acid | |
2-(4-benzofuro[3,2-d]pyrimidinylthio)-1-thiophen-2-ylethanone
[no description available] | 2.03 | 1 | 0 | benzofurans | |
3,5,5-trimethyl-2-sulfanylidene-1,6-dihydrobenzo[h]quinazolin-4-one
[no description available] | 2.03 | 1 | 0 | quinazolines | |
phenylthiazolylthiourea
Phenylthiazolylthiourea: A dopamine-beta-hydroxylase inhibitor. | 2.06 | 1 | 0 | | |
2-amino-4-(4-chlorophenyl)-6-methyl-3-pyridinecarbonitrile
[no description available] | 2.03 | 1 | 0 | phenylpyridine | |
1,6-dimethyl-3-(2-pyridinyl)pyrimido[5,4-e][1,2,4]triazine-5,7-dione
[no description available] | 2.03 | 1 | 0 | pyrimidotriazine | |
2-mercaptonaphth(2,3)imidazole
2-mercaptonaphth(2,3)imidazole: exhibits phosphorescence | 2.06 | 1 | 0 | | |
1-(4-methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone
[no description available] | 2.03 | 1 | 0 | quinoxaline derivative | |
N-[3-cyano-4-(4-methoxyphenyl)-5-methyl-2-thiophenyl]-2-methyl-3-pyrazolecarboxamide
[no description available] | 2.03 | 1 | 0 | methoxybenzenes | |
chlorogenic acid
caffeoylquinic acid: Antiviral Agent; structure in first source. chlorogenate : A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3. | 1.99 | 1 | 0 | cinnamate ester;
tannin | food component;
plant metabolite |
2-(4-fluorophenyl)-3-(2-furanylmethyl)-10-methylpyrimido[4,5-b]quinoline-4,5-dione
[no description available] | 2.03 | 1 | 0 | quinolines | |
6-(4-bromophenyl)-3-methyl-1-[2-(2H-tetrazol-5-yl)ethyl]-4-(trifluoromethyl)pyrazolo[3,4-b]pyridine
[no description available] | 2.03 | 1 | 0 | phenylpyridine | |
3-phenyl-2-sulfanylidene-1H-benzofuro[3,2-d]pyrimidin-4-one
[no description available] | 2.03 | 1 | 0 | benzofurans | |
2-[(4-methylphenyl)sulfonylamino]acetic acid [2-(5-bromo-2-thiophenyl)-2-oxoethyl] ester
[no description available] | 2.03 | 1 | 0 | alpha-amino acid ester | |
2-[(6-chloro-1H-benzimidazol-2-yl)thio]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
[no description available] | 2.03 | 1 | 0 | benzimidazoles | |
p-201-1
[no description available] | 2.06 | 1 | 0 | | |
2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(3-methylphenyl)acetamide
[no description available] | 2.03 | 1 | 0 | benzofurans | |
2-amino-7,7-dimethyl-4-(4-methylphenyl)-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbothioamide
[no description available] | 2.03 | 1 | 0 | toluenes | |
1-(3-methyl-1-piperidinyl)-2-(2-quinoxalinylthio)ethanone
[no description available] | 2.03 | 1 | 0 | quinoxaline derivative | |
2-(5-bromo-2-thiophenyl)-N-(4-methyl-1-piperazinyl)-4-quinolinecarboxamide
[no description available] | 2.03 | 1 | 0 | quinolines | |
3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5-thione
[no description available] | 2.03 | 1 | 0 | triazoles | |
2-(2-quinoxalinylthio)propanoic acid
[no description available] | 2.03 | 1 | 0 | quinoxaline derivative | |
3-hydroxyblancoxanthone
3-hydroxyblancoxanthone: from the root of Calophyllum blancoi; structure in first source | 2.41 | 1 | 0 | pyranoxanthones | |
mangostin
mangostin: xanthone from rind of Garcinia mangostana Linn. fruit. alpha-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities. | 2.41 | 1 | 0 | aromatic ether;
phenols;
xanthones | antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite |
myricitrin
myricitrin: isolated from root bark of Myrica cerifera L.; structure. myricitrin : A glycosyloxyflavone that consists of myricetin attached to a alpha-L-rhamnopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Myrica cerifera, it exhibits anti-allergic activity. | 2.48 | 2 | 0 | alpha-L-rhamnoside;
glycosyloxyflavone;
monosaccharide derivative;
pentahydroxyflavone | anti-allergic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
plant metabolite |
cynarine
cynarine: active principle of the artichoke; functions primarily as a cholagogue and choleretic and also as antilipemic agent | 2.06 | 1 | 0 | alkyl caffeate ester;
quinic acid | plant metabolite |
ellagic acid
[no description available] | 2.03 | 1 | 0 | catechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol | antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent |
fumarprotocetraric acid
fumarprotocetraric acid: RN given refers to (E)-isomer; structure given in first source | 1.99 | 1 | 0 | carbonyl compound | |
4-methylesculetin
4-methylesculetin: has antiinflammatory activity. 6,7-dihydroxy-4-methylcoumarin : A hydroxycoumarin that is 4-methylcuomarin which is substituted by hydroxy groups at positions 3 and 4. A hyaluronan synthesis inhibitor. It has also been used as a fluorescent sensor to monitor the consumption of a boronic acid in Suzuki coupling reactions; fluorescence is readily detectable by the naked eye using a standard 365 nm UV lamp. | 2.06 | 1 | 0 | hydroxycoumarin | anti-inflammatory agent;
antioxidant;
hyaluronan synthesis inhibitor |
salazinic acid
salazinic acid: lichen metabolite; structure in first source | 1.99 | 1 | 0 | | |
aluminum
Aluminum: A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. | 1.95 | 1 | 0 | boron group element atom;
elemental aluminium;
metal atom | |
5,6-dichloro-1H-imidazo[4,5-b]pyrazine-2-carboxylic acid
[no description available] | 2.08 | 1 | 0 | imidazopyrazine | |
3-bromo-7-hydroxy-4,8-dimethyl-1-benzopyran-2-one
[no description available] | 2.03 | 1 | 0 | hydroxycoumarin | |
4,5-di-O-caffeoylquinic acid
[no description available] | 1.99 | 1 | 0 | quinic acid | |
3-(3-methylphenyl)-2-sulfanylidene-1H-benzofuro[3,2-d]pyrimidin-4-one
[no description available] | 2.03 | 1 | 0 | benzofurans | |
6-(4-bromophenyl)-2-methyl-3-pyridinecarboxylic acid
[no description available] | 2.03 | 1 | 0 | phenylpyridine | |
lissamine rhodamine b
lissamine rhodamine : An organic sodium salt having 4-[3,6-bis(diethylamino)xanthenium-9-yl]benzene-1,3-disulfonate as the counterion. | 2.03 | 1 | 0 | organic sodium salt | fluorescent probe;
fluorochrome;
histological dye |
methacycline monohydrochloride
[no description available] | 2.03 | 1 | 0 | | |
streptovaricin c
streptovaricin C: structure given in first source | 2.08 | 1 | 0 | | |
galloflavin
galloflavin: structure in first source | 2.48 | 2 | 0 | | |